4.6 Article

Exceptional thermal stability of therapeutical enzymes entrapped in alumina sol-gel matrices

期刊

JOURNAL OF MATERIALS CHEMISTRY B
卷 2, 期 19, 页码 2868-2873

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/c3tb21643h

关键词

-

资金

  1. Hebrew University
  2. FTA program of the Israel Ministry of Trade and Industry

向作者/读者索取更多资源

Alumina sol-gel matrices emerge in this study as very interesting biocompatible superior materials for entrapment and stabilization of enzymes. Three therapeutic enzymes were selected for this study: acid phosphatase (AcP) which is used for treatment of bone dysplasia; a peroxidase (HRP), used for release of toxic drugs in vivo from their pro-drugs; and asparaginase (ASP) used for starving cancerous leukemia cells. The thermal stability of enzyme@alumina is so high that by heating, for instance, AcP@alumina to 60 degrees C, the enzymatic activity is not only kept, but actually increases, whereas is solution at that temperature there is total denaturation; and cycles of heating-cooling AcP@alumina at that temperature leave it unaffected. An unprecedented increase of six-orders of magnitude in the Arrhenius pre-factor was observed! This indicates the beneficial role of the microporosity in this type of entrapment. This exceedingly high stability is seen also with the other two enzymes: thus, when HRP or ASP are heated in solution to 75 degrees C the activity drops by 65% and 72%, respectively, but when entrapped it drops only by 1.2% and 1.9%, respectively. The thermal stability was studied in detail, by the follow-up of kinetics, by differential scanning calorimetry and by circular dichroism. These techniques indicate that the entrapment shifts the temperatures of denaturation higher by 30-50 degrees C. A special protein-friendly synthetic procedure using ultrasound was developed for the synthesis of these biomaterials. As alumina is already approved for injections (as an adjuvant in vaccinations), these findings highlight the possibility of overcoming the hurdle of the use of sol-gel materials as injectable carriers of therapeutic components.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据